ZWJ Investment Counsel’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.02M Buy
6,688
+751
+13% +$767K 0.26% 67
2026
Q1
$5.46M Sell
5,937
-431
-7% -$437K 0.2% 69
2025
Q4
$6.84M Sell
6,368
-162
-2% -$155K 0.25% 62
2025
Q3
$4.98M Buy
6,530
+183
+3% +$136K 0.18% 68
2025
Q2
$4.95M Sell
6,347
-47
-0.7% -$36.5K 0.18% 69
2025
Q1
$5.28M Sell
6,394
-21
-0.3% -$17.5K 0.21% 68
2024
Q4
$4.95M Buy
6,415
+36
+0.6% +$29.8K 0.2% 68
2024
Q3
$5.65M Buy
6,379
+4
+0.1% +$3.6K 0.23% 64
2024
Q2
$5.77M Buy
6,375
+30
+0.5% +$24K 0.25% 63
2024
Q1
$4.94M Buy
6,345
+174
+3% +$124K 0.22% 64
2023
Q4
$3.6M Sell
6,171
-49
-0.8% -$28.6K 0.19% 69
2023
Q3
$3.34M Buy
6,220
+162
+3% +$83.5K 0.19% 70
2023
Q2
$2.84M Sell
6,058
-150
-2% -$62.9K 0.15% 73
2023
Q1
$2.13M Buy
6,208
+68
+1% +$22.9K 0.12% 78
2022
Q4
$2.25M Hold
6,140
0.13% 79
2022
Q3
$1.99M Sell
6,140
-6
-0.1% -$1.9K 0.12% 80
2022
Q2
$1.99M Buy
6,146
+451
+8% +$135K 0.12% 79
2022
Q1
$1.63M Hold
5,695
0.09% 88
2021
Q4
$1.57M Hold
5,695
0.08% 90
2021
Q3
$1.32M Buy
5,695
+150
+3% +$37K 0.07% 93
2021
Q2
$1.27M Sell
5,545
-327
-6% -$65.7K 0.07% 94
2021
Q1
$1.1M Sell
5,872
-38
-0.6% -$7.43K 0.07% 98
2020
Q4
$998K Buy
5,910
+105
+2% +$15.7K 0.07% 97
2020
Q3
$859K Sell
5,805
-105
-2% -$16.3K 0.07% 91
2020
Q2
$970K Sell
5,910
-43
-0.7% -$6.6K 0.08% 82
2020
Q1
$826K Buy
5,953
+365
+7% +$50.2K 0.07% 107
2019
Q4
$734K Buy
5,588
+313
+6% +$36.3K 0.05% 127
2019
Q3
$590K Hold
5,275
0.05% 104
2019
Q2
$584K Hold
5,275
0.05% 104
2019
Q1
$684K Sell
5,275
-6
-0.1% -$730 0.06% 95
2018
Q4
$611K Buy
5,281
+6
+0.1% +$670 0.06% 102
2018
Q3
$566K Hold
5,275
0.05% 108
2018
Q2
$450K Hold
5,275
0.04% 111
2018
Q1
$408K Sell
5,275
-649
-11% -$52.2K 0.04% 110
2017
Q4
$500K Buy
5,924
+15
+0.3% +$1.28K 0.04% 166
2017
Q3
$505K Sell
5,909
-273
-4% -$22.4K 0.04% 159
2017
Q2
$509K Sell
6,182
-386
-6% -$31.5K 0.04% 169
2017
Q1
$552K Buy
6,568
+434
+7% +$34.8K 0.05% 162
2016
Q4
$451K Buy
6,134
+847
+16% +$63.1K 0.04% 116
2016
Q3
$425K Buy
5,287
+112
+2% +$8.96K 0.04% 114
2016
Q2
$408K Hold
5,175
0.04% 116
2016
Q1
$373K Sell
5,175
-36
-0.7% -$2.72K 0.04% 119
2015
Q4
$439K Buy
5,211
+36
+0.7% +$2.99K 0.05% 112
2015
Q3
$433K Hold
5,175
0.05% 105
2015
Q2
$432K Hold
5,175
0.05% 111
2015
Q1
$376K Sell
5,175
-50
-1% -$3.56K 0.04% 118
2014
Q4
$361K Hold
5,225
0.04% 118
2014
Q3
$339K Hold
5,225
0.04% 120
2014
Q2
$325K Hold
5,225
0.04% 118
2014
Q1
$308K Hold
5,225
0.04% 118
2013
Q4
$266K Sell
5,225
-150
-3% -$7.51K 0.03% 121
2013
Q3
$270K Buy
5,375
+61
+1% +$3.19K 0.03% 117
2013
Q2
$261K Buy
+5,314
New +$289K 0.04% 115

Other funds holding LLY

ZWJ Investment Counsel's LLY Position: Q2 2026 in Review

ZWJ Investment Counsel increased its Eli Lilly (LLY) stake by 13% in Q2 2026, buying an estimated $767K and bringing the position to 6,688 shares worth $8.02M. The position accounts for 0.26% of the portfolio, ranked #67.

ZWJ Investment Counsel first reported a position in LLY in Q2 2013 and has held it in 53 quarters since. 1,558 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • ZWJ Investment Counsel held 6,688 shares of Eli Lilly worth $8.02M as of Q2 2026.
  • ZWJ Investment Counsel bought 751 Eli Lilly shares in Q2 2026, an estimated $767K.
  • Eli Lilly made up 0.26% of ZWJ Investment Counsel's portfolio in Q2 2026, its #67 holding.
  • ZWJ Investment Counsel first reported a position in Eli Lilly in Q2 2013 and has held it in 53 quarters since.
  • 1,558 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on ZWJ Investment Counsel's 13F filing for Q2 2026, filed 16 Jul 2026.